233 related articles for article (PubMed ID: 8411353)
21. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
22. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
Chiu HC; Yao SY; Wang CT
J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
[TBL] [Abstract][Full Text] [Related]
23. Specific incorporation of cyclophilin A into HIV-1 virions.
Franke EK; Yuan HE; Luban J
Nature; 1994 Nov; 372(6504):359-62. PubMed ID: 7969494
[TBL] [Abstract][Full Text] [Related]
24. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
Park J; Morrow CD
J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
[TBL] [Abstract][Full Text] [Related]
25. Transport and assembly of gag proteins into Moloney murine leukemia virus.
Hansen M; Jelinek L; Whiting S; Barklis E
J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996
[TBL] [Abstract][Full Text] [Related]
26. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
Berkowitz RD; Luban J; Goff SP
J Virol; 1993 Dec; 67(12):7190-200. PubMed ID: 8230441
[TBL] [Abstract][Full Text] [Related]
27. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
[TBL] [Abstract][Full Text] [Related]
28. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
Colgan J; Yuan HE; Franke EK; Luban J
J Virol; 1996 Jul; 70(7):4299-310. PubMed ID: 8676452
[TBL] [Abstract][Full Text] [Related]
29. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
Ako-Adjei D; Johnson MC; Vogt VM
J Virol; 2005 Nov; 79(21):13463-72. PubMed ID: 16227267
[TBL] [Abstract][Full Text] [Related]
30. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses.
Manrique ML; González SA; Affranchino JL
Virology; 2004 Nov; 329(1):157-67. PubMed ID: 15476883
[TBL] [Abstract][Full Text] [Related]
31. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
32. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
[TBL] [Abstract][Full Text] [Related]
33. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.
Srinivasakumar N; Hammarskjöld ML; Rekosh D
J Virol; 1995 Oct; 69(10):6106-14. PubMed ID: 7666514
[TBL] [Abstract][Full Text] [Related]
34. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
Bowzard JB; Bennett RP; Krishna NK; Ernst SM; Rein A; Wills JW
J Virol; 1998 Nov; 72(11):9034-44. PubMed ID: 9765448
[TBL] [Abstract][Full Text] [Related]
35. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
Paxton W; Connor RI; Landau NR
J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
[TBL] [Abstract][Full Text] [Related]
36. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
37. Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.
Wei M; Yang Y; Niu M; Desfosse L; Kennedy R; Musier-Forsyth K; Kleiman L
J Virol; 2008 Dec; 82(24):12049-59. PubMed ID: 18842718
[TBL] [Abstract][Full Text] [Related]
38. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Kiernan RE; Ono A; Englund G; Freed EO
J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
[TBL] [Abstract][Full Text] [Related]
39. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
40. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.
Gregory DA; Lyddon TD; Johnson MC
J Virol; 2013 Feb; 87(3):1518-27. PubMed ID: 23152533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
